Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-treatment dipyridamole effects on nucleoside transport inhibition
NL-OMON34866Active, not recruiting
- Sponsor
- Pharmacology-Toxicology
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of dipyridamole (2 arms), sponsored by Pharmacology-Toxicology. Primary endpoint: Nucleoside uptake inhibition. Started Mar 2010; status: active, not recruiting.
02
Drugs
dipyridamole
Beyond the preview
Go deeper on NL-OMON34866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34866.